SLC23A2: A Potential Drug Target for Cancer and Other Diseases

Target Name: SLC23A2

NCBI ID: G9962

SLC23A2

SLC23A2: A Potential Drug Target for Cancer and Other Diseases

SLC23A2 (NBTL1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the nucleotide transport family 1 (NUPT) and is responsible for carrying out a critical function in the regulation of DNA replication and gene expression.

SLC23A2 has been identified as a potential drug target due to its involvement in a variety of cellular processes that are important for human health. One of the key targets of SLC23A2 is the DNA replication process, which is critical for the development and maintenance of cancer. SLC23A2 has been shown to play a role in regulating the growth and survival of various cancer cell types, including breast, ovarian, and colorectal cancer.

In addition to its role in cancer development, SLC23A2 has also been shown to be involved in a variety of other cellular processes that are important for normal cellular function. For example, SLC23A2 is involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs. SLC23A2 has also been shown to play a role in the regulation of the immune response, which is important for maintaining cellular and tissue health.

SLC23A2 has also been shown to be involved in the regulation of inflammation, which is a critical aspect of the immune response. SLC23A2 has been shown to play a role in the regulation of the production of pro-inflammatory cytokines, which are important for the recruitment of immune cells to the site of inflammation.

In conclusion, SLC23A2 is a protein that is involved in a variety of cellular processes that are important for human health. Its potential as a drug target makes it an attractive target for researchers to investigate and develop new treatments for a variety of diseases. Further studies are needed to fully understand the role of SLC23A2 in cellular processes and its potential as a drug target.

Protein Name: Solute Carrier Family 23 Member 2

Functions: Sodium/ascorbate cotransporter (PubMed:10471399, PubMed:10556521). Mediates electrogenic uptake of vitamin C, with a stoichiometry of 2 Na(+) for each ascorbate (PubMed:10471399)

The "SLC23A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC23A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets